Pril-series Intermediate Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Benazepril, Cilazapril, Quinapril, And Ramipril); Formulation (Tablet, Capsule, Others); Application (Strokes, Hypertension, And Kidney Issues)

Report Code: TIPRE00018836 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Pril-series intermediate are used to treat high blood pressure, heart failure, and diabetic kidney disease. These act as an ACE inhibitor and works by relaxing blood vessels for easy blood flow.

MARKET DYNAMICS

the pril-series intermediate market is driving due to increasing prevalence of cardiovascular diseases. However, side effects such as dizziness, cough, and light-headedness is expected to hamper the growth of the global pril-series intermediate market. Moreover, product launches is anticipated to drive demand the growth of the market.

MARKET SCOPE

The "Pril-series Intermediate Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Pril-series Intermediate market with detailed market segmentation type, and application. The Pril-series Intermediate market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Pril-series Intermediate market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Pril-series Intermediate market is segmented based on type, formulation, and application. Based on type, the market is segmented into benazepril, cilazapril, quinapril, and ramipril. Based on formulation, the market is segmented into tablet, capsule, and others. Based on application, the market is segmented into strokes, hypertension, and kidney issues.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Pril-series Intermediate market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pril-series Intermediate market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Pril-series Intermediate market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Pril-series Intermediate market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Pril-series Intermediate market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Pril-series Intermediate market are anticipated to have lucrative growth opportunities in the future with the rising demand for Pril-series Intermediate market in the global market. Below mentioned is the list of few companies engaged in the Pril-series Intermediate market.

The report also includes the profiles of key players in Pril-series Intermediate market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- ScinoPharm Taiwan, Ltd
- Farmhispania, S.A.
- Aarti Industries Ltd
- Wisdom Pharmaceutical Co., Ltd.
- Zhejiang Huahai Pharmaceutical Co
- Aurobindo Pharma Limited
- Amino Chemicals
- Lupin Ltd
- LGC Limited
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pril-series Intermediate Market - By Type
1.3.2 Pril-series Intermediate Market - By Formulation
1.3.3 Pril-series Intermediate Market - By Application
1.3.4 Pril-series Intermediate Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PRIL-SERIES INTERMEDIATE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PRIL-SERIES INTERMEDIATE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PRIL-SERIES INTERMEDIATE MARKET - GLOBAL MARKET ANALYSIS
6.1. PRIL-SERIES INTERMEDIATE - GLOBAL MARKET OVERVIEW
6.2. PRIL-SERIES INTERMEDIATE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PRIL-SERIES INTERMEDIATE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BENAZEPRIL
7.3.1. Overview
7.3.2. Benazepril Market Forecast and Analysis
7.4. CILAZAPRIL
7.4.1. Overview
7.4.2. Cilazapril Market Forecast and Analysis
7.5. QUINAPRIL
7.5.1. Overview
7.5.2. Quinapril Market Forecast and Analysis
7.6. AND RAMIPRIL
7.6.1. Overview
7.6.2. And Ramipril Market Forecast and Analysis
8. PRIL-SERIES INTERMEDIATE MARKET - REVENUE AND FORECASTS TO 2028 - FORMULATION
8.1. OVERVIEW
8.2. FORMULATION MARKET FORECASTS AND ANALYSIS
8.3. TABLET
8.3.1. Overview
8.3.2. Tablet Market Forecast and Analysis
8.4. CAPSULE
8.4.1. Overview
8.4.2. Capsule Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. PRIL-SERIES INTERMEDIATE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. STROKES
9.3.1. Overview
9.3.2. Strokes Market Forecast and Analysis
9.4. HYPERTENSION
9.4.1. Overview
9.4.2. Hypertension Market Forecast and Analysis
9.5. AND KIDNEY ISSUES
9.5.1. Overview
9.5.2. And Kidney Issues Market Forecast and Analysis
10. PRIL-SERIES INTERMEDIATE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pril-series Intermediate Market Overview
10.1.2 North America Pril-series Intermediate Market Forecasts and Analysis
10.1.3 North America Pril-series Intermediate Market Forecasts and Analysis - By Type
10.1.4 North America Pril-series Intermediate Market Forecasts and Analysis - By Formulation
10.1.5 North America Pril-series Intermediate Market Forecasts and Analysis - By Application
10.1.6 North America Pril-series Intermediate Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pril-series Intermediate Market
10.1.6.1.1 United States Pril-series Intermediate Market by Type
10.1.6.1.2 United States Pril-series Intermediate Market by Formulation
10.1.6.1.3 United States Pril-series Intermediate Market by Application
10.1.6.2 Canada Pril-series Intermediate Market
10.1.6.2.1 Canada Pril-series Intermediate Market by Type
10.1.6.2.2 Canada Pril-series Intermediate Market by Formulation
10.1.6.2.3 Canada Pril-series Intermediate Market by Application
10.1.6.3 Mexico Pril-series Intermediate Market
10.1.6.3.1 Mexico Pril-series Intermediate Market by Type
10.1.6.3.2 Mexico Pril-series Intermediate Market by Formulation
10.1.6.3.3 Mexico Pril-series Intermediate Market by Application
10.2. EUROPE
10.2.1 Europe Pril-series Intermediate Market Overview
10.2.2 Europe Pril-series Intermediate Market Forecasts and Analysis
10.2.3 Europe Pril-series Intermediate Market Forecasts and Analysis - By Type
10.2.4 Europe Pril-series Intermediate Market Forecasts and Analysis - By Formulation
10.2.5 Europe Pril-series Intermediate Market Forecasts and Analysis - By Application
10.2.6 Europe Pril-series Intermediate Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pril-series Intermediate Market
10.2.6.1.1 Germany Pril-series Intermediate Market by Type
10.2.6.1.2 Germany Pril-series Intermediate Market by Formulation
10.2.6.1.3 Germany Pril-series Intermediate Market by Application
10.2.6.2 France Pril-series Intermediate Market
10.2.6.2.1 France Pril-series Intermediate Market by Type
10.2.6.2.2 France Pril-series Intermediate Market by Formulation
10.2.6.2.3 France Pril-series Intermediate Market by Application
10.2.6.3 Italy Pril-series Intermediate Market
10.2.6.3.1 Italy Pril-series Intermediate Market by Type
10.2.6.3.2 Italy Pril-series Intermediate Market by Formulation
10.2.6.3.3 Italy Pril-series Intermediate Market by Application
10.2.6.4 Spain Pril-series Intermediate Market
10.2.6.4.1 Spain Pril-series Intermediate Market by Type
10.2.6.4.2 Spain Pril-series Intermediate Market by Formulation
10.2.6.4.3 Spain Pril-series Intermediate Market by Application
10.2.6.5 United Kingdom Pril-series Intermediate Market
10.2.6.5.1 United Kingdom Pril-series Intermediate Market by Type
10.2.6.5.2 United Kingdom Pril-series Intermediate Market by Formulation
10.2.6.5.3 United Kingdom Pril-series Intermediate Market by Application
10.2.6.6 Rest of Europe Pril-series Intermediate Market
10.2.6.6.1 Rest of Europe Pril-series Intermediate Market by Type
10.2.6.6.2 Rest of Europe Pril-series Intermediate Market by Formulation
10.2.6.6.3 Rest of Europe Pril-series Intermediate Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pril-series Intermediate Market Overview
10.3.2 Asia-Pacific Pril-series Intermediate Market Forecasts and Analysis
10.3.3 Asia-Pacific Pril-series Intermediate Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Pril-series Intermediate Market Forecasts and Analysis - By Formulation
10.3.5 Asia-Pacific Pril-series Intermediate Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Pril-series Intermediate Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pril-series Intermediate Market
10.3.6.1.1 Australia Pril-series Intermediate Market by Type
10.3.6.1.2 Australia Pril-series Intermediate Market by Formulation
10.3.6.1.3 Australia Pril-series Intermediate Market by Application
10.3.6.2 China Pril-series Intermediate Market
10.3.6.2.1 China Pril-series Intermediate Market by Type
10.3.6.2.2 China Pril-series Intermediate Market by Formulation
10.3.6.2.3 China Pril-series Intermediate Market by Application
10.3.6.3 India Pril-series Intermediate Market
10.3.6.3.1 India Pril-series Intermediate Market by Type
10.3.6.3.2 India Pril-series Intermediate Market by Formulation
10.3.6.3.3 India Pril-series Intermediate Market by Application
10.3.6.4 Japan Pril-series Intermediate Market
10.3.6.4.1 Japan Pril-series Intermediate Market by Type
10.3.6.4.2 Japan Pril-series Intermediate Market by Formulation
10.3.6.4.3 Japan Pril-series Intermediate Market by Application
10.3.6.5 South Korea Pril-series Intermediate Market
10.3.6.5.1 South Korea Pril-series Intermediate Market by Type
10.3.6.5.2 South Korea Pril-series Intermediate Market by Formulation
10.3.6.5.3 South Korea Pril-series Intermediate Market by Application
10.3.6.6 Rest of Asia-Pacific Pril-series Intermediate Market
10.3.6.6.1 Rest of Asia-Pacific Pril-series Intermediate Market by Type
10.3.6.6.2 Rest of Asia-Pacific Pril-series Intermediate Market by Formulation
10.3.6.6.3 Rest of Asia-Pacific Pril-series Intermediate Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pril-series Intermediate Market Overview
10.4.2 Middle East and Africa Pril-series Intermediate Market Forecasts and Analysis
10.4.3 Middle East and Africa Pril-series Intermediate Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Pril-series Intermediate Market Forecasts and Analysis - By Formulation
10.4.5 Middle East and Africa Pril-series Intermediate Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Pril-series Intermediate Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pril-series Intermediate Market
10.4.6.1.1 South Africa Pril-series Intermediate Market by Type
10.4.6.1.2 South Africa Pril-series Intermediate Market by Formulation
10.4.6.1.3 South Africa Pril-series Intermediate Market by Application
10.4.6.2 Saudi Arabia Pril-series Intermediate Market
10.4.6.2.1 Saudi Arabia Pril-series Intermediate Market by Type
10.4.6.2.2 Saudi Arabia Pril-series Intermediate Market by Formulation
10.4.6.2.3 Saudi Arabia Pril-series Intermediate Market by Application
10.4.6.3 U.A.E Pril-series Intermediate Market
10.4.6.3.1 U.A.E Pril-series Intermediate Market by Type
10.4.6.3.2 U.A.E Pril-series Intermediate Market by Formulation
10.4.6.3.3 U.A.E Pril-series Intermediate Market by Application
10.4.6.4 Rest of Middle East and Africa Pril-series Intermediate Market
10.4.6.4.1 Rest of Middle East and Africa Pril-series Intermediate Market by Type
10.4.6.4.2 Rest of Middle East and Africa Pril-series Intermediate Market by Formulation
10.4.6.4.3 Rest of Middle East and Africa Pril-series Intermediate Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pril-series Intermediate Market Overview
10.5.2 South and Central America Pril-series Intermediate Market Forecasts and Analysis
10.5.3 South and Central America Pril-series Intermediate Market Forecasts and Analysis - By Type
10.5.4 South and Central America Pril-series Intermediate Market Forecasts and Analysis - By Formulation
10.5.5 South and Central America Pril-series Intermediate Market Forecasts and Analysis - By Application
10.5.6 South and Central America Pril-series Intermediate Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pril-series Intermediate Market
10.5.6.1.1 Brazil Pril-series Intermediate Market by Type
10.5.6.1.2 Brazil Pril-series Intermediate Market by Formulation
10.5.6.1.3 Brazil Pril-series Intermediate Market by Application
10.5.6.2 Argentina Pril-series Intermediate Market
10.5.6.2.1 Argentina Pril-series Intermediate Market by Type
10.5.6.2.2 Argentina Pril-series Intermediate Market by Formulation
10.5.6.2.3 Argentina Pril-series Intermediate Market by Application
10.5.6.3 Rest of South and Central America Pril-series Intermediate Market
10.5.6.3.1 Rest of South and Central America Pril-series Intermediate Market by Type
10.5.6.3.2 Rest of South and Central America Pril-series Intermediate Market by Formulation
10.5.6.3.3 Rest of South and Central America Pril-series Intermediate Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PRIL-SERIES INTERMEDIATE MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PRIL-SERIES INTERMEDIATE MARKET, KEY COMPANY PROFILES
13.1. SCINOPHARM TAIWAN, LTD
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. FARMHISPANIA, S.A.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. AARTI INDUSTRIES LTD
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. WISDOM PHARMACEUTICAL CO., LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ZHEJIANG HUAHAI PHARMACEUTICAL CO
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. AUROBINDO PHARMA LIMITED
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. AMINO CHEMICALS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. LUPIN LTD
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. LGC LIMITED
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. ScinoPharm Taiwan, Ltd
2. Farmhispania, S.A.
3. Aarti Industries Ltd
4. Wisdom Pharmaceutical Co., Ltd.
5. Zhejiang Huahai Pharmaceutical Co
6. Aurobindo Pharma Limited
7. Amino Chemicals
8. Lupin Ltd
9. LGC Limited
TIPRE00018836
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking